• ქართული
  • English
  • Takeda gets China's approval for $62 billion Shire purchase

    Takeda Pharmaceutical Co Ltd said on Friday China approved its purchase of Shire Plc, the latest regulator to clear the $62 billion deal and bring the Japanese group closer to becoming a global top 10 drugmaker.

    Market Quotes by TradingView